ID: ALA3985437

Max Phase: Preclinical

Molecular Formula: C20H20N2O5

Molecular Weight: 368.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc(OC)c1-c1cccc(C(CC(=O)O)c2nnc(C)o2)c1

Standard InChI:  InChI=1S/C20H20N2O5/c1-12-21-22-20(27-12)15(11-18(23)24)13-6-4-7-14(10-13)19-16(25-2)8-5-9-17(19)26-3/h4-10,15H,11H2,1-3H3,(H,23,24)

Standard InChI Key:  IUZDFIHBUTUINR-UHFFFAOYSA-N

Associated Targets(Human)

Lysosomal protective protein 919 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 368.39Molecular Weight (Monoisotopic): 368.1372AlogP: 3.67#Rotatable Bonds: 7
Polar Surface Area: 94.68Molecular Species: ACIDHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.16CX Basic pKa: CX LogP: 2.03CX LogD: -1.03
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.68Np Likeness Score: -0.31

References

1.  (2015)  Biaryl-propionic acid derivatives and their use as pharmaceuticals, 

Source

Source(1):